Mito-PQQ

Name: Mito-PQQ
Brand: Designs for Health

BrandDesigns for Health→Other Combinations Capsule 4 ingredients 1 caution DSLD #22784

Net contents: 60 Vegetarian Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2013-06-25

2 Ingredients (4)

IngredientGroupSafety

RhodiolaRhodiola Conditionally Safe

Pyrroloquinoline quinone disodium saltPyrroloquinoline Quinone—

Microcrystalline CelluloseCellulose—

Vegetable StearateMagnesium stearateUse with Caution

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Rhodiola — Conditionally Safe

⚠ Insomnia if taken late

⚠ MAOI-like activity

Sodium — Limited Evidence

⚠ Hypertension

⚠ Fluid retention

Magnesium — Use with Caution

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID22784

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2013-06-25

6 More from Designs for Health

View Designs for Health Safety Scorecard → 261 products

5-HTP Supreme 5-HTP Synergy 7-Keto Acetyl L-Carnitine Acnutrol Adrenal Complex

7 Cite this page

Vancouver

Pkhakadze G. Mito-PQQ — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 16]. Available from: https://supplement.ge/products/mito-pqq-22784/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG